Omaxe Limited (BOM:532880)
India · Delayed Price · Currency is INR 78.18
+0.59 (0.76%)
At close: May 27, 2026
Omaxe Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 12,534 | 15,610 | 16,143 | 7,733 | 6,178 | |
Revenue Growth (YoY) | -19.71% | -3.30% | 108.75% | 25.17% | 29.87% |
Cost of Revenue | 17,619 | 20,108 | 17,895 | 8,663 | 5,576 |
Gross Profit | -5,085 | -4,499 | -1,752 | -929.6 | 602.2 |
Selling, General & Admin | 245.1 | 905.8 | 751 | 740.1 | 637.9 |
Other Operating Expenses | 1,628 | 673.1 | 875.9 | 1,243 | 432.8 |
Operating Expenses | 2,218 | 1,946 | 2,170 | 2,637 | 1,537 |
Operating Income | -7,303 | -6,444 | -3,921 | -3,567 | -934.3 |
Interest Expense | -2,551 | -1,641 | -1,051 | -929.6 | -1,024 |
Interest & Investment Income | - | 285.2 | 142.2 | 145.4 | 106.2 |
Earnings From Equity Investments | -0.1 | -2.7 | 2.3 | - | 0.4 |
Other Non Operating Income (Expenses) | 863.4 | -256.4 | -221.2 | -161 | -147 |
EBT Excluding Unusual Items | -8,991 | -8,059 | -5,049 | -4,512 | -1,999 |
Gain (Loss) on Sale of Investments | - | - | -53.9 | -120 | - |
Gain (Loss) on Sale of Assets | - | 98.4 | 5 | 9 | 37.5 |
Other Unusual Items | - | 320.3 | 26.8 | 55 | 17.8 |
Pretax Income | -8,991 | -7,640 | -5,071 | -4,568 | -1,943 |
Income Tax Expense | -2,023 | -786.2 | -1,012 | -1,057 | -327.3 |
Earnings From Continuing Operations | -6,968 | -6,854 | -4,059 | -3,511 | -1,616 |
Minority Interest in Earnings | -0.6 | -6 | 33.1 | 31.7 | 20.8 |
Net Income | -6,969 | -6,860 | -4,026 | -3,479 | -1,595 |
Net Income to Common | -6,969 | -6,860 | -4,026 | -3,479 | -1,595 |
Shares Outstanding (Basic) | 183 | 183 | 183 | 183 | 183 |
Shares Outstanding (Diluted) | 183 | 183 | 183 | 183 | 183 |
Shares Change (YoY) | 0.00% | - | - | - | - |
EPS (Basic) | -38.10 | -37.51 | -22.01 | -19.02 | -8.72 |
EPS (Diluted) | -38.10 | -37.51 | -22.01 | -19.02 | -8.72 |
Free Cash Flow | 1,824 | 9,826 | 9,699 | 4,516 | 7,659 |
Free Cash Flow Per Share | 9.97 | 53.72 | 53.03 | 24.69 | 41.88 |
Gross Margin | -40.57% | -28.82% | -10.85% | -12.02% | 9.75% |
Operating Margin | -58.27% | -41.28% | -24.29% | -46.12% | -15.12% |
Profit Margin | -55.60% | -43.95% | -24.94% | -44.99% | -25.82% |
Free Cash Flow Margin | 14.56% | 62.95% | 60.08% | 58.40% | 123.98% |
EBITDA | -6,958 | -6,343 | -3,821 | -3,469 | -830.6 |
EBITDA Margin | -55.52% | -40.63% | -23.67% | -44.86% | -13.44% |
D&A For EBITDA | 345.1 | 101.6 | 100.5 | 97.2 | 103.7 |
EBIT | -7,303 | -6,444 | -3,921 | -3,567 | -934.3 |
EBIT Margin | -58.27% | -41.28% | -24.29% | -46.12% | -15.12% |
Revenue as Reported | 13,397 | 16,370 | 16,349 | 7,980 | 6,379 |
Advertising Expenses | - | 664.9 | 405.2 | 346.5 | 234.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.